Cyclophosphamide induced CD11b+ cells can inhibit anti-CD40 monoclonal antibody (mAb) therapy of B-cell lymphoma

被引：0
|
作者：
Honeychurch, J [1 ]
Glennie, MJ [1 ]
Johnson, PW [1 ]
Illidge, TM [1 ]
机构：
[1] Univ Southampton, Canc Sci Div, Southampton, Hants, England
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.3280.3280
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3280
引用
收藏
页码：896A / 896A
页数：1
相关论文
共 50 条
  • [41] Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies
    R. O. Dillman
    Clinical and Experimental Medicine, 2006, 6
  • [42] Differences in IgE isotype switching induced by anti-CD40 monoclonal antibody and cytokines among subtypes of chronic B lymphoid leukemias
    Takeuchi, H
    Kayano, H
    Hirose, T
    EXPERIMENTAL HEMATOLOGY, 2000, 28 (05) : 543 - 550
  • [43] Ku in the cytoplasm associates with CD40 in human B cells and translocates into the nucleus following incubation with IL-4 and anti-CD40 mAb
    Morio, T
    Hanissian, SH
    Bacharier, LB
    Teraoka, H
    Nonoyama, S
    Seki, M
    Kondo, J
    Nakano, H
    Lee, SK
    Geha, RS
    Yata, J
    IMMUNITY, 1999, 11 (03) : 339 - 348
  • [44] Systemic therapy with cyclophosphamide and anti-CD20 antibody (rituximab) in relapsed primary cutaneous B-cell lymphoma: A report of 7 cases
    Fierro, MT
    Savoia, P
    Quaglino, P
    Novelli, M
    Barberis, M
    Bernengo, MG
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (02) : 281 - 287
  • [45] CD32B, the human inhibitory Fc-γ receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma
    Rankin, Christopher T.
    Veri, Maria-Concetta
    Gorlatov, Sergey
    Tuaillon, Nadine
    Burke, Steve
    Huang, Ling
    Inzunza, H. David
    Li, Hua
    Thomas, Shannon
    Johnson, Syd
    Stavenhagen, Jeffrey
    Koenig, Scott
    Bonvini, Ezio
    BLOOD, 2006, 108 (07) : 2384 - 2391
  • [46] Treatment of radiation-relapsing primary cutaneous B-cell lymphoma with an anti-CD20 monoclonal antibody
    Lacouture, ME
    Baron, JM
    Jani, AB
    Laumann, AE
    Soltani, K
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2005, 30 (01) : 46 - 48
  • [47] Enhanced T Cell-Independent Anti-tumor Effect of Cyclophosphamide Combined With Anti-CD40 MAB and CpG
    Johnson, Erik E.
    Buhtoiarov, Ilia N.
    Waisbren, Julie B.
    Sondel, Paul M.
    Rakhmilevich, Alexander L.
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 954 - 954
  • [48] Mechanism of action on B cell lymphoma by chimeric anti-CD20 monoclonal antibody
    T Oyama
    Y Kagami
    M Seto
    Y Morishima
    Leukemia, 2001, 15 : 1667 - 1667
  • [49] EBV HUMAN B-CELL LYMPHOMAS IN SCID MICE - DESCRIPTION OF THE MODEL AND STUDY OF THE ROLE OF ANTI-CD40 AND ANTI-CD23 MONOCLONAL-ANTIBODIES IN THEIR DEVELOPMENT
    GARNIER, JL
    CANNON, MJ
    CHARGUI, J
    TOURAINE, JL
    COOPER, NR
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 1387 - 1388
  • [50] Mechanism of action on B cell lymphoma by chimeric anti-CD20 monoclonal antibody
    Oyama, T
    Kagami, Y
    Seto, M
    Morishima, Y
    LEUKEMIA, 2001, 15 (10) : 1667 - 1667
12345